Cancer Research

Drug resistance, tumor heterogeneity, metastasis, immunotherapy, adoptive cell transfer including CAR T-cells, tumor microenvironment, tertiary lymphoid structures, extracellular vesicles, siRNA therapeutics, predictive and prognostic biomarkers, genomics and epigenetics in Cancer, single-Cell Sequencing, cancer organoids, patient-derived xenograft (PDX) models and in Vivo Imaging.